[Response to the comments on the contributions "Hypertonic solutions in heart surgery" and "Hypertonic hyperoncotic volume replacement (7.5 % NaCl/10 % hydroxyethyl starch 200,000/0.5) in patients with coronary artery stenoses" by H. Böhrer and E. Martin].
Prien
T
T
D001810:Blood Volume / Q000502:physiology*; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000503:physiopathology / Q000601:surgery*; D005110:Extracellular Space / Q000502:physiology; D006438:Hemodilution; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage*; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage*; D014882:Water-Electrolyte Balance / Q000502:physiology
D006895:Hydroxyethyl Starch Derivatives; D012462:Saline Solution, Hypertonic